Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
11%
Ph not_applicable
6
67%
Ph phase_3
1
11%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(7)
Other(1)

Detailed Status

Completed7
unknown1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (12.5%)
Phase 31 (12.5%)
N/A6 (75.0%)

Trials by Status

unknown111%
completed778%
enrolling_by_invitation111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
9